logo

For the Inventor, By the Inventor

London, Canada

Robarts Research Institute

Calculating rank
USPTO Granted Patents = 13

% Expired Patents = 53.8



Forward Citations = 44

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Aaron Fenster (4 out of 40 patents)

silverMedal Grant McFadden (4 out of 15 patents)

bronzeMedal Donal B Downey (3 out of 12 patents)

4.  Mickie Bhatia (3 out of 4 patents)

5.  John Cameron Bell (2 out of 30 patents)

6.  John Barrett (2 out of 5 patents)

7.  Lori Anne Gardi (2 out of 2 patents)

8.  Jennifer Jean Trowbridge (2 out of 2 patents)

9.  Randall Todd Moon (2 out of 9 patents)

10.  Jeffrey Bax (1 out of 9 patents)

11.  Arthur Brown (1 out of 4 patents)

12.  Paul Gris (1 out of 1 patent)

13.  Chandima Edirisinghe (1 out of 1 patent)

14.  Mingyue Ding (1 out of 1 patent)

15.  Robert G Pinkerton (1 out of 1 patent)


13 patents:

1. 9980994 - Myxoma virus mutants for cancer treatment (2018-05-29),
2. 9070190 - Ultrasound imaging system and methods of imaging using the same (2015-06-30),
3. 8899125 - Counterbalance assembly (2014-12-02),
4. 8791084 - Inhibition of SOX9 function in the treatment of proteoglycan-associated pathophysiological conditions (2014-07-29),
5. 8788019 - System and method for performing a biopsy of a target volume and a computing device for planning the same (2014-07-22),
6. 8512713 - Myxoma virus mutants for cancer treatment (2013-08-20),
7. 8444543 - Apparatus and computing device for performing brachytherapy and methods of imaging using the same (2013-05-21),
8. 8372397 - Methods for regulation of stem cells (2013-02-12),
9. 8227440 - Use of Myxoma virus for the therapeutic treatment of cancer and chronic viral infection (2012-07-24),
10. 8193812 - Transceive surface coil array for magnetic resonance imaging and spectroscopy (2012-06-05),
11. 7850960 - Methods for regulation of stem cells (2010-12-14),
12. 7582614 - Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection (2009-09-01),
13. 7527968 - Regeneration initiating cells (2009-05-05),
Company Overview
Robarts Research Institute, located in London, Canada, is a leading biomedical research facility dedicated to advancing health through innovative research. The institute specializes in various domains, including imaging, neuroscience, and regenerative medicine, focusing on translating scientific discoveries into clinical applications. With a collaborative approach, Robarts fosters partnerships with academic institutions and healthcare organizations to drive breakthroughs in medical science and improve patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#15 in London

#1,166 in Canada

#45,081 in the World

London, CA
London, Canada

Robarts Research Institute

Forward Citations = 44

16 inventors:

goldMedal Aaron Fenster (4 out of 40 patents)

silverMedal Grant McFadden (4 out of 15 patents)

bronzeMedal Donal B Downey (3 out of 12 patents)

4.  Mickie Bhatia (3 out of 4 patents)

5.  John Cameron Bell (2 out of 30 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Robarts Research Institute. Retrieved from https://idiyas.com/company/robarts-research-institute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…